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Abstract Three adenine nucleotide translocase isoforms 
(ANT1, ANT2 and ANT3) are coded by different genes. The 
relative amounts of the three ANT isoform mRNAs were 
determined in detail in various human tissues. ANT isoforms 
were co-expressed in all tested tissues revealing tissue-specific 
transcription patterns. The highest ANT1 mRNA proportions 
were found in terminally differentiated tissues like skeletal 
muscle, heart and brain, whereas ANT2 was mainly expressed in 
tissues capable of proliferation and regeneration as in the 
kidneys, spleen, liver, fibroblasts and lymphocytes. The ANT3 
mRNA proportion was not prominently expressed in any of the 
tissues tested. In conclusion, tissue-specific expression of ANT 
isoforms is strongly related to the state of cellular differentiation. 
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1. Introduction 
Adenine nucleotide translocase (ANT) is an integral protein 
of the inner mitochondrial  membrane and consists of two 
identical 32 kDa subunits with a single binding site for ATP 
and ADP that alternatively faces the matrix (m conformation) 
or the cytosolic side of the membrane (c conformation) [1]. 
Dependent on the conformational  change of ANT, mitochon- 
drial ATP  is exchanged for cytosolic ADP at a 1 : 1 ratio. Since 
ANT is the only mitochondrial  translocase for nucleotides, it 
is the most important  link between energy-producing and en- 
ergy-consuming processes. 
Immunological  investigations pointed for the first time to 
the existence of ANT isoforms, since antibodies against ANT 
protein isolated from heart muscle tissue showed only a par- 
tial cross-reactivity o ANT protein from the kidneys and liver 
[2,3]. Molecular biological investigations confirmed the pres- 
ence of at least three different human genes for ANT,  desig- 
nated ANT1, ANT2 and ANT3 [4,5]. The ANTI gene is lo- 
cated on chromosome 4, wherease ANT2 is found on the X 
chromosome [6,7]. The locus of the ANT3 gene is still 
unknown. ANT genes have similar structural features consist- 
ing of 4 exons of identical ength and a 77 79% homology of 
the nucleotide sequence. However, their respective 5' flanking 
regions are distinct and show different promotor  elements 
[4,8,9]. These different regulatory structures uggest various 
regulating mechanisms for the three isoforms in relation to 
their development and/or cellular metabolism. 
Thus far, the exact proport ions of the three human ANT 
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isoform transcripts have not been defined. For this reason, we 
determined the relative amount  of the ANT isoform transcrip- 
tion to get an accurate picture of the tissue-specific ANT iso- 
form expression patterns in different human tissues. 
2. Materials and methods 
2.1. Materials 
Skeletal muscle (n = 8), left cardiac ventricle, brain, kidney, spleen 
and liver specimens (n = 18 of each) were investigated for tissue-spe- 
cific ANT isoform expression. Human autopsies were performed with- 
in 24 h after death. Furthermore, myocardial specimens (intraventric- 
ular septum, left and right ventricle) obtained from patients 
undergoing heart transplantation due to coronary heart disease 
(n = 25) were immediately snap-frozen in liquid nitrogen after remov- 
al. In the same way, specimens from atrial auricles were obtained 
from patients undergoing valvular surgery (n= 12). All tissues were 
stored at -80°C until analysis. 
Human fibroblasts were cultured in MEM medium supplemented 
with 10% fetal calf serum at 37°C and 5% CO2. Cells were harvested 
in the log phase of growth. 
Lymphocytes were isolated from blood of 11 persons by Ficoll 
centrifugation according to the manufacturer's instructions (Pharma- 
cia Biotech, Uppsala, Sweden). 
2.2. Determination f ANT isoform-~pecific mRNA proportions 
Total RNA was extracted using the LiCI method [10] and was 
reverse-transcribed into cDNA (Gibco BRC, Eggenstein, Germany). 
Amplification of ANT-specific DNA was carried out in a PCR reaction 
mixture containing 50 mM Tris-HCl, 50 mM KCI, 0.001% gelatine, 1.5 
mM MgC12, 0.4 ~M of each primer (5': 5'-CTG CTG CTG CAG 
GTC CAG CA-3' and 3': 5'-CCT GAC TGC ATC ATC AT-3') and 
0.25 U ofTaq polymerase (Cetus Perkin Elmer, Weiterstadt, Germany). 
The denaturation, annealing and extension conditions for the total 
ANT cDNA amplification were 2 min for each period of cycle at 
94°C, 57°C and 72°C, respectively. Thirty-five amplification cycles 
were performed with a thermal cycler (Biometra, G6ttingen, Ger- 
many). Contamination and non-specificity of reaction were ruled 
out by control reactions not including cDNA as a template. The 
primers used are located in the coding regions of the ANT isoform 
cDNAs (Fig. 1). They are complementary to regions sharing nearly 
identical sequences within the isoform cDNAs. Thus, the amplifica- 
tion resulted in a mixture containing ANT1, ANT2 and ANT3 PCR 
products, each of them 629 bp long (Fig. 2A), with identical end 
sequences but different ANT isoform-specific intermediate nucleotide 
sequences. Therefore, ANT1, ANT2 and ANT3 isoform cDNA was 
amplified in relation to ANT isoform mRNA distribution in the 
orginal tissue. 
Next, the proportions of ANT isoform-specific sequences in this 
mixture were determined by a special dot-blot hybridization proce- 
dure. Aliquots of the PCR product -- containing the mixture of am- 
plified ANT1, ANT2 and ANT3 isoform cDNA -- were denaturated 
in 1 vol% 0.5 M NaOH, 1 M NaCI and spotted in triplicate onto three 
nylon membranes (Amersham, Germany). Additionally, an ANTl 
isoform-specific DNA standard (constructed as described below) 
was spotted in a dilution of 840  fmol onto the first of these nylon 
membranes; an ANT2 isoform-specific cDNA standard was applied 
in the same dilution onto the second membrane, and the third nylon 
membrane obtained the ANT3 isoform-specific cDNA standard. The 
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membranes were air-dried for l h. Prehybridization was performed in
gold hybridization buffer (Amersham, Germany) for 1 h at 42°C. The 
membranes were then hybridized according to the blotted ANT iso- 
form-specific standards with corresponding 3Zp-radiolabeled ANT iso- 
form-specific oligonucleotides (for the first membrane ANTI: 5'- 
GGC AAG GGC GCC GCC CAG CG-3', for the second mem- 
brane ANT2: 5'-GCT GGA GCT GAA AGG GAA TT-3' and for 
the third membrane ANT3: 5'-ATC GTG GAC TGC ATT 
GTC CG-Y). After hybridization at 42°C overnight, he membranes 
were briefly washed in 6 × SSPE, 0.1% Triton X-100 at room temper- 
ature and for 10 rain at 42°C. This was followed by a final wash step 
at high-stringency onditions in 3 M tetramethylammonium chloride 
(TMACI: Sigma, Deisenhofen, Germany), 0.1% Triton X-100 at 62°C 
for 30 min. Each dot was cut out of the membrane and measured in [3- 
counter. Standard curves were calculated using known molarities of 
the ANT isol\~rm-specific standards. The measured radioactivity of 
the samples was compared to the corresponding standard curves, 
and the proportions of the ANT1, ANT2 and ANT3 isoforms were 
calculated. 
2.3. Preparation of ANT isojorm standards 
Isoform-specific cDNA standards were amplified by PCR using 
heart-specific cDNA as template and isoform-specific primer pairs 
shown in Table 1. The annealing temperatures for ANT1 amplifica- 
tion was 60°C for ANT2 55°C and for ANT3 70°C. The PCR reaction 
mixture was the same as described above. Specificity of standards and 
oligonucleotides u ed for hybridization were confirmed by Southern 
blotting (Fig. 2B) and restriction analysis (data not shown). Each of 
the obtained PCR products was cloned into the TA pCR2.1 cloning 
vector (Fa. Invitrogen NV, Leek) according to the manufacturer's 
instructions. Cloned inserts were reamplified by PCR using the pri- 
mers previously mentioned and the respective ANT isoform-specific 
vector as template. Thereafter, PCR products were purified from pri- 
mers, protein and salt using QIAquick PCR purification spins (QIA- 
GEN, Hilden, Germany). The eluated ANT isolorm-specific PCR 
products were measured spectrometrically and diluted to 40 fmol sol- 
utions. 
2.4. Southern blot 
The PCR products were subjected to electrophoresis on a 2% agar- 
ose gel in 50 mM Tris-borate, 1mM EDTA. After denaturation in 0.5 
M NaOH, 1.5 M NaC1 for 30 min, the PCR products were capillarly 
transferred onto a nylon membrane (N + Hybond, Fa. Amersham, 
Braunschweig, Germany) in 0.4 M NaOH overnight. The membrane 
was dried and hybridized with ANT-specific oligonucleotides as de- 
scribed for the dot-blot procedure. 
3. Results 
The relative amount of ANT isoform-specific mRNA was 
determined in human tissue from different sources. In order to 
prove the accuracy of the method used and guarantee that the 
results were not falsified by RNA degradation, the ANT iso- 
form distribution of left ventricular tissue from explanted 
hearts immediately snap-frozen i liquid nitrogen after remov- 
al was compared to the isoform pattern of left ventricular 
autopsy material. As shown in Fig. 3, the ANT isoform pat- 
terns of both groups were identical. Thus, the ANT propor- 
tions were n~t distorted by possible RNA degradation in 
autopsy tissue. Additionally, although PCR analyses were per- 
formed with different amounts of cDNA, various numbers of 
PCR cycles and annealing temperatures, the PCR products 
obtained differed only in their cDNA amount but not in the 
ANT isoform proportions (data not shown). 
ANT1 5"(lbp) • • (104bp)ATG ~ (204-223bp) 
ANT2 5"(lbp) • (69bp) ATG ~ (169-185bp) 
ANT3 5"(1) • • (82bp) ATG 
ANT isoform-specific cDNA 
(816-832bp) ~ TAP, • • • (1300bp) 3" 
(781-797bp) - -  TAA • • = (1289bp) 3" 
(181-201bp) (793-810bp) ~ TAA • • • • (1426bp)3" 
~, Amplification of the ANT isoform sequences by PCR using 
primers which are complementary to all ANT sequences 
I 1 ~ 
'l* ~ || PCRMixturePrOduCt:of ANT1- ANT2- and ANT3- 1 511-530bp 
I I |" specific cDNA in their original ii ' 242-261bp r I ~ ~ tissue-specific proportions 
Determination of the percentages of ANT1-, ANT2- and ANT3-specific cDNA 
in the PCR mixture by dot blot hybridization using ANT type-specific radiolabled oligonucleotides 
and ANT isoform-specific cDNA as reference 
D°tb l ° t l  l :  : ° ° ° O O 0  i Diluti°n °f ANTIspecific c D N p c R  product 
Dotblot2 : : o o O O O Q  :DilutionofANT2-specificcDNApcRproduct 
Dotblot3 : : : " " " " ~11DilutiOn°fANT3specificcDNAPCRproduct 
Measurement of the radioactivity of the bond oligonucleotides of each dot and calculation of the percentages of each 
ANT isoform-specific sequence in the PCR product using ANT-specific cDNA as reference. 
Fig. I. All ANT isoform-specific sequences were coamplified in a single PCR reaction using only one primer pair that hybridizes to homolo- 
gous sequences of the three ANT isoforms. The amplification resulted in a mixture of ANT1-, ANT2- and ANT3-specific sequences in relation 
to the ANT isoform mRNA distribution of the original tissue. The proportions of amplified isoform-specific cDNA in the PCR mixture were 
finally determined by dot-blot hybridization with isoform-specific radiolabeled (*) oligonucleotides and ANT isoform-specific cDNAs as stand- 
ards. Regions of primer hybridization are marked. Radioactivity of the samples was measured and compared to the corresponding standard. 
The proportion of each isoform was calculated. 
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Fig. 2. A: PCR was carried out with ANT isoform-specific primer pairs to amplify ANT1-, ANT2- and ANT3-specific cDNA standards. The 
PCR products were subjected to electrophoresis n an agarose gel containing ethidium bromide. The PCR product of ANT1 is 1072 bp (lane 
1), ANT2 is 1044 bp (lane 2) and ANT3 is 416 bp (lane 3). Lane 4 shows the PCR product of total ANT cDNA from heart with a length of 
629 bp amplified with a primer pair wh ch recognizes homologous sequences of ANT1, ANT2 and ANT3. B: The PCR products were blotted 
onto three nylon membranes by Southern blotting. Each blot was hybridized with radiolabeled oligonucleotides specific for (a) ANT1, 
(b) ANT2 and (c) ANT3. All oligonucleotides hybridized to the total ANT PCR product (lane 4) and to each of their specific PCR products. 
No cross-reactions were se n. 
The tissues analyzed could be separated into two groups 
differing in their ability to regenerate and grade of differentia- 
tion. The first group was made up of tissues like skeletal 
muscles, heart and brain which are terminally differentiated 
and incapable of regeneration. Kidneys, spleen, liver, prolif- 
erating cultured fibroblasts and lymphocytes which keep their 
capacity of regeneration by mitotic division were grouped in a 
second collective. The ANT isoform transcription pattern dif- 
fered significantly in these groups. The ANT isoform tran- 
scription pattern of terminally differentiated tissues is charac- 
terized by a predominant ANT1 expression. Here, the 
proportion of ANT1 transcription ranges from 56+6 to 
69+6% (Table 2). Hereby, the percentages of ANT1 tran- 
scription in heart and skeletal muscle tissue indicate no 
marked variations. However, in comparison to muscle tissue, 
the proportion of ANT1 mRNA in the brain is significantly 
lower. In contrast to the first group, the proportion of ANT1 
transcription of tissues capable of regeneration varies between 
14+ 1% and 29 + 6%, whereby proliferating fibroblasts indi- 
cate the lowest proportion of ANT1 transcription. 
However, ANT 2 is the prevalent isoform of tissues quali- 
fied for mitotic division. ANT2 mRNA proportions varied 
between 56 + 9% and 77 + 8% in these organs. In contrast, 
the ANT2 mRNA proportion of terminally differentiated tis- 
sues amounts only to a fourth of the total ANT transcription. 
ANT3 expression is not prominent in any of the tissue 
tested. The percentages of ANT3 transcription ranges from 
an average of 7+3% in the heart and lymphocytes to 
29 + 3% in fibroblasts. 
Beside the description of the organ-specific ANT isoform 
transcription pattern, the ANT isoform distribution of various 
regions of the heart like left and right ventricle, septum and 
auricle were compared (Fig. 4). The different heart regions 
indicate a common ANT isoform transcription pattern with- 
out any variation. 
4. Discussion 
Immunological studies of ANT protein isolated from the 
heart, kidneys and liver provided evidence of organ-specific 
determinants and the existence of at least three ANT isoforms 
[2,3]. Furthermore, data from molecular biological studies 
employing the Northern blot technique provided a rough eval- 
uation of the ANT isoform transcription level in various hu- 
man tissues [6,11,12]. However, up to this date, there was no 
information about the exact proportions of ANT isoform 
transcripts in various mammalian tissues. Therefore, we deter- 
mined the percentages of each isoform in a variety of human 
organs by employing the PCR technique combined with a dot- 
blot hybridization procedure. This technique is applied to de- 
Table 1 
Primer used for the amplification of ANTI-, ANT2- and ANT3-specific cDNA 
Primer Primer sequence cDNA region 
(bp) 
ANT1 
Forward primer 
Reverse primer 
ANT2 
Forward primer 
Reverse primer 
ANT3 
Forward primer 
Reverse primer 
5'-CTG AGA GCG TCG AGC TGT CA-3' 
5'-CTC AAT GAA GCA TCT CTT C-3' 
5'-CCG CAG CGC CGT AGT CAA A-3' 
5'-AGT CTG TCA AGA ATG CTC AA-3' 
5'-CCG TTC TCC GGC TGT CCT CC-3' 
5'-GCC GGC CGC ACC GCC GGA GGC-3' 
83- 102 
1136-1154 
1- 19 
1025-1044 
39-58 
434- 454 
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Fig. 3. ANT isoform mRNA proportions of left ventricular tissue 
obtained from autopsies (n= 18: open bars) and explanted hearts 
(n = 25: tilled bars). Data are shown as mean + SD. 
termine ANT isoform mRNA proportions of total ANT tran- 
scripts in very small tissue biopsies (3 mg wet weight). 
Differences regarding the expression of ANT isoforms ob- 
viously depend on the state of cellular differention. ANT!  
gene expression predominantly occurs in skeletal muscles, 
heart and brain, and thus, in cells that are terminally differ- 
entiated and incapable of mitotic division. In these tissues, the 
ANT2 and ANT3 transcription is of minor significance. These 
findings correspond to the data of Stepien et al. [11], who 
showed that ANT2 is the prevalent isoform in myoblasts dur- 
ing cell proliferation and in the early stage of differentiation, 
whereas ANT1 is poorly expressed. However, a dramatic in- 
crease in ANTI transcription took place at the final differ- 
entiation stage, while the ANT2 mRNA level decreases. 
In contrast o a predominant ANT1 expression in termi- 
nally differentiated tissues, a prevailing ANT2 expression oc- 
curs in tissues that are able to regeneration by mitotic 
division. ANT2 is a growth-regulated gene known to be highly 
expressed in a variety of proliferating cells [13-16]. In addition 
to these data, we report here a prevalence of ANT2 expression 
in proliferating fibroblasts with an isoform proportion pattern 
similar to that observed in the kidneys, liver, spleen and lym- 
phocytes. 
None of the tissue investigated demonstrated any predom- 
inance of ANT3 expression. ANT3 is assumed to be a house- 
keeping ene which is influenced to a lesser extent by the state 
of cellular development [4]. This notion is supported by the 
observation that ANT3 expression is not altered during 
muscle cell differentiation [11], as shown for ANTI and 
ANT2 transcription. Furthermore, there was no significant 
change of ANT3 transcription during the cultivation of 
HeLa cells when the cell culture reached the late log phase, 
as it was observed for ANT2 [12]. 
The reported ata explain the findings of Schultheiss et al. 
[2,3] and Rojo et al. [17]. Both authors showed a particular 
cross-reactivity of antibodies against ANT protein from heart 
with ANT protein isolated from the kidneys and liver. These 
antibodies are mainly reactive against ANTI, which is the 
predominant isoform of the heart. Since the proportion of 
ANTI is low in kidney and liver, they react only to a small 
part of ANT protein isolated from these tissues that consists 
mainly of ANT2 protein. Additionally, Rojo et al. found sim- 
ilar antigenic properties between ANT protein from the heart 
and brain corresponding to the ANT isoform mRNA pattern 
shown by our data. 
The physiological significance of tissue-specific ANT iso- 
forms is probably additionally related to different functional 
properties of the isoform proteins. Since the human ANT 
isoform proteins have not yet been isolated, detailed data 
about the kinetic characteristics of the individual isoforms 
are still lacking. However, Klingenberg found a lower ANT 
transport rate in mammalian heart mitochondria compared to 
liver mitochondria [18]. Since we measured a predominant 
ANTI expression i  the heart and a prevalent ANT2 expres- 
sion in the liver, it may be assumed that the ANt1 isoform 
has a lower transport capacity than ANT2. This hypothesis 
supported by a kinetic analysis of the ADP/ATP-carrier 
(ACC1-3) of yeast. Here, the nucleotide transport rate of 
ACC1 protein is approximately 40% of the ACC2 nucleotide 
transport rate [19,20]. In the mammalian heart, an elevated 
ANT protein density that are four times higher than in the 
liver [18,21] may compensate he lower ANT1 isoform trans- 
port rate. Further analyses of ANT isoform kinetics till have 
to be carried out. 
In summary, we present the tissue-specific transcription pat- 
tern of the ANT isoforms ANTI, ANT2 and ANT3 in vari- 
ous human tissues. Since ANT3 is always subordinately ex- 
pressed. Thus, alterations in the ANT isoform mRNA pattern 
mainly depend on the differential transcription of ANT1 and 
ANT2. We conclude from our data that the distinct expres- 
sion of the ANT isoforms is strongly related to the state of 
cellular differentiation, with a predominance of ANTI in ter- 
minally differentiated tissues, and a prevalent ANT2 expres- 
sion in tissues capable of regeneration and proliferation. We 
Table 2 
ANT isoform mRNA proportions in various human tissues 
Tissue ANT1 ANT2 ANT3 
('7,,) ('7,,) ('7o) 
Terminally differentiated tissues: No mitotic division Skeletal muscles 69_+ 6 20_+ 5 11 _+ 3 
Heart 68_+5 25_+ 5 7_+ 3 
Brain 56+_6 27_ + 6 17_+: 5 
Kidney 29 _+ 6 56 +_ 9 15 _+: 7 
Spleen 23_+3 56+_ 9 21_+: 6 
Liver 15 _+ 6 63 +_ 11 22 +- 10 
Fibroblast 14_+1 57_ + 3 29-+: 3 
Lymphocyte 16_+ 5 77 _+ 5 7 -+ 4 
Tissues with the ability to regenerate by mitotic division 
Data are shown as mean + SD. 
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Fig. 4. ANT isoform mRNA proportions of samples from left and 
right ventricle, septum (n =25 of each) and from auricle (n= 12). 
Data are shown as mean + SD. 
postulate that ANT isoform expression may be related to cell 
cycle control. 
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